Global Topical Mupirocin Ointment Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

According to our (Global Info Research) latest study, the global Topical Mupirocin Ointment market size was valued at US$ 493 million in 2024 and is forecast to a readjusted size of USD 610 million by 2031 with a CAGR of 3.1% during review period.

Topical Mupirocin is an antibiotic that prevents bacteria from growing on skin. Mupirocin Ointment (for use on the skin) is used to treat skin infections such as impetigo (IM-pe-TYE-go) or a "Staph" infection of the skin.

The topical mupirocin ointment market is driven by the increasing prevalence of skin infections, including impetigo, as well as the rising incidence of antibiotic-resistant bacterial strains like MRSA (methicillin-resistant Staphylococcus aureus). Topical Mupirocin ointment is widely used as a topical antibiotic for treating various bacterial skin infections, making it an essential product in both hospitals and community healthcare settings. The growing awareness of effective wound care, along with increased healthcare access in developing regions, is also contributing to the demand for topical mupirocin ointment.

A key challenge in the topical mupirocin ointment market is the potential for bacterial resistance due to the overuse or misuse of antibiotics, which can reduce the long-term efficacy of the product. Additionally, competition from alternative topical antibiotics and newer antimicrobial therapies could limit market growth. Pricing pressures, particularly in regions with generic product availability, may also impact market share and profitability for branded formulations. Furthermore, stringent regulatory requirements for manufacturing and product approval add to the complexity of market entry for new player.

Currently, global production of topical Mupirocin Ointment is concentrated as there are few manufacturers engaged in the industry. The largest manufacturer is SmithKline & French, who owns 24% revenue market share. As for the region, North America is the largest consumption region, holding 35% revenue market share, followed by China, with 22% market share. Mupirocin Ointment is used to treat certain skin infections (such as impetigo). It is an antibiotic. It works by stopping the growth of certain bacteria. Among various applications, demand from Retail Pharmacy is the largest sold channel.

This report is a detailed and comprehensive analysis for global Topical Mupirocin Ointment market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.

Key Features:

Global Topical Mupirocin Ointment market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031

Global Topical Mupirocin Ointment market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031

Global Topical Mupirocin Ointment market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031

Global Topical Mupirocin Ointment market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Topical Mupirocin Ointment

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Topical Mupirocin Ointment market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Glenmark Pharms, Glaxosmithkline, SmithKline & French, Humanwell Healthcare, Taro Pharmaceutical, Teva, Perrigo, Hanzhou Zhuyangxin Pharmaceutical, GSK, Sun Pharmaceutical, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market Segmentation

Topical Mupirocin Ointment market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type

5 Grams

15 Grams

22 Grams

Others

Market segment by Application

Hospital

Retail Pharmacy

Others

Major players covered

Glenmark Pharms

Glaxosmithkline

SmithKline & French

Humanwell Healthcare

Taro Pharmaceutical

Teva

Perrigo

Hanzhou Zhuyangxin Pharmaceutical

GSK

Sun Pharmaceutical

Bausch Health

Market segment by region, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)

South America (Brazil, Argentina, Colombia, and Rest of South America)

Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Topical Mupirocin Ointment product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top manufacturers of Topical Mupirocin Ointment, with price, sales quantity, revenue, and global market share of Topical Mupirocin Ointment from 2020 to 2025.

Chapter 3, the Topical Mupirocin Ointment competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Topical Mupirocin Ointment breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.

Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Topical Mupirocin Ointment market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.

Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.

Chapter 13, the key raw materials and key suppliers, and industry chain of Topical Mupirocin Ointment.

Chapter 14 and 15, to describe Topical Mupirocin Ointment sales channel, distributors, customers, research findings and conclusion.